Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bilateral papillary muscle rupture after myocardial infarction.
Uruno K, Iwano H, Nishioka N, Naraoka S. Uruno K, et al. Among authors: nishioka n. Eur Heart J Cardiovasc Imaging. 2025 Jan 8:jeaf005. doi: 10.1093/ehjci/jeaf005. Online ahead of print. Eur Heart J Cardiovasc Imaging. 2025. PMID: 39777486 No abstract available.
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy.
Kawachi H, Yamada T, Tamiya M, Negi Y, Kijima T, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Katayama Y, Nishioka N, Morimoto K, Iwasaku M, Tokuda S, Shimose T, Takayama K. Kawachi H, et al. Among authors: nishioka n. Oncoimmunology. 2025 Dec;14(1):2442116. doi: 10.1080/2162402X.2024.2442116. Epub 2024 Dec 16. Oncoimmunology. 2025. PMID: 39681395 Free PMC article.
Patients' Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan.
Ogura Y, Iwasaku M, Ishida M, Katayama Y, Nishioka N, Morimoto K, Yamamoto C, Tokuda S, Kaneko Y, Yamada T, Yamazaki H, Inoue M, Ikai H, Takayama K. Ogura Y, et al. Among authors: nishioka n. Cancer Control. 2024 Jan-Dec;31:10732748241305234. doi: 10.1177/10732748241305234. Cancer Control. 2024. PMID: 39613477 Free PMC article.
The "invisible ceiling" of bystander CPR in three Asian countries: Descriptive study of national OHCA registry.
Okada Y, Hong KJ, Lim SL, Hong D, Ng YY, Leong BS, Jun Song K, Ho Park J, Sun Ro Y, Kitamura T, Nishiyama C, Matsuyama T, Kiguchi T, Nishioka N, Iwami T, Do Shin S, Eh Ong M, Javid Siddiqui F. Okada Y, et al. Among authors: nishioka n. Resuscitation. 2025 Jan;206:110445. doi: 10.1016/j.resuscitation.2024.110445. Epub 2024 Nov 28. Resuscitation. 2025. PMID: 39613139
Usefulness of a dedicated laser-cut metal stent with an anchoring hook and thin delivery system for EUS-guided hepaticogastrostomy in malignant biliary obstruction: a prospective multicenter trial (with video).
Itonaga M, Ogura T, Isayama H, Takenaka M, Hijioka S, Ishiwatari H, Ashida R, Okuda A, Fujisawa T, Minaga K, Takeshita K, Yamashita Y, Nishioka N, Ishii S, Omoto S, Ohtsuka T, Sofue K, Yasuda I, Shimokawa T, Kitano M. Itonaga M, et al. Among authors: nishioka n. Gastrointest Endosc. 2024 Nov 8:S0016-5107(24)03686-1. doi: 10.1016/j.gie.2024.11.005. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39521097
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with NSCLC with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs Chemoimmunotherapy: A Multicenter, Retrospective Study.
Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. Nishioka N, et al. Cancer Res Treat. 2024 Oct 25. doi: 10.4143/crt.2024.748. Online ahead of print. Cancer Res Treat. 2024. PMID: 39482992 Free article.
Technical feasibility of EUS-guided liver abscess drainage for the right hepatic lobe using a novel metal stent as first-line treatment (with video).
Ogura T, Ueno S, Okuda A, Nishioka N, Sakamoto J, Yamada M, Yamamura M, Uba Y, Tomita M, Hattori N, Nakamura J, Bessho K, Nishikawa H. Ogura T, et al. Among authors: nishioka n. Gastrointest Endosc. 2024 Sep 12:S0016-5107(24)03494-1. doi: 10.1016/j.gie.2024.09.013. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39276803
The Significance of Longitudinal Psoas Muscle Loss in Predicting the Maintenance Efficacy of Durvalumab Treatment Following Concurrent Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer: A Retrospective Study.
Kuno H, Nishioka N, Yamada T, Kunimatsu Y, Yoshimura A, Hirai S, Futamura S, Masui T, Egami M, Chihara Y, Takayama K. Kuno H, et al. Among authors: nishioka n. Cancers (Basel). 2024 Aug 30;16(17):3037. doi: 10.3390/cancers16173037. Cancers (Basel). 2024. PMID: 39272894 Free PMC article.
490 results